首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   84篇
  免费   2篇
耳鼻咽喉   4篇
儿科学   4篇
妇产科学   4篇
基础医学   9篇
口腔科学   1篇
临床医学   11篇
内科学   21篇
皮肤病学   4篇
外科学   8篇
综合类   1篇
预防医学   14篇
药学   4篇
肿瘤学   1篇
  2022年   2篇
  2021年   2篇
  2017年   2篇
  2015年   2篇
  2014年   4篇
  2013年   4篇
  2012年   1篇
  2011年   1篇
  2010年   8篇
  2008年   3篇
  2007年   1篇
  2006年   1篇
  2005年   3篇
  2001年   1篇
  1999年   1篇
  1997年   4篇
  1996年   5篇
  1995年   3篇
  1993年   4篇
  1992年   1篇
  1991年   4篇
  1990年   4篇
  1989年   1篇
  1988年   1篇
  1987年   2篇
  1986年   3篇
  1985年   2篇
  1984年   3篇
  1983年   3篇
  1982年   1篇
  1981年   3篇
  1980年   2篇
  1975年   1篇
  1965年   1篇
  1957年   1篇
  1956年   1篇
排序方式: 共有86条查询结果,搜索用时 15 毫秒
71.
We examined the feasibility of administering nearly 100% oxygenthroughout the induction-delivery period of general anaesthesiafor 113 Caesarean sections. Isoflurane 1.25% was compared with1.5% enflurane for maintenance of anaesthesia. The level ofanaesthesia was monitored by use of the isolated forearm technique.There was a greater amount of isolated forearm movement whenenflurane was used. The three main criteria for a satisfactorygeneral anaesthetic technique for Caesarean section were fulfilled,namely no maternal awareness, no undue depression of the fetusand no adverse effect on uterine contractility. Isoflurane andenflurane appear to be suitable anaesthetic agents for facilitatinghyper-oxygenation during Caesarean section.  相似文献   
72.
73.
A case is reported of a 34-year-old woman who developed diffuse hair loss after taking moclobemide 300 mg bd for 1 week, having previously taken 150 mg bd for 4 weeks without hair loss. Although the hair loss ceased 2 weeks after stopping moclobemide, her hair had not recovered at 6 months after stopping treatment. Other reports of hair loss on antidepressants are reviewed. © 1997 John Wiley & Sons, Ltd.  相似文献   
74.
75.
76.
Inherent risks of stenting include restenosis and thrombosis. Recently, stent fractures have been recognized as a complication that may result in thrombosis, perforation, restenosis, and migration of the stent resulting in morbidity and mortality. Stent fractures were originally seen in the superficial femoral arteries but have since then been reported in almost all vascular sites including the coronary, renal, carotid, iliac, and femoropopliteal arteries. Fractures are the result of the complex interplay between stent manufacturing, the stented segment, pulsatile and nonpulsatile biomechanical forces, and plaque morphology at a particular vascular site. The presentation of a patient with a fracture is highly variable, ranging from asymptomatic in nature, detected on routine screening without any sequelae, to sudden cardiac death related to a thrombosed coronary artery. Despite being recognized as an important complication, consensus on routine surveillance and diagnostic methods to detect fractures continues to be lacking. Fortunately, most cases are relatively benign and can be managed conservatively if detected. In the setting of recurrent symptoms, further intervention is usually sought. In review of the literature most cases are managed with placement of a stent over the fractured area, the stent‐in‐stent technique, but several other alternatives may be available. As the knowledge of the variables that make stents prone to fracture are identified, better technologies and techniques can be employed to minimize the risk of this complication. This article reviews the available literature on stent fractures and complications using data found on PubMed, MEDLINE, the Manufacturer and User Facility Device Experience (MAUDE) database, and the Cochrane databases. (J Interven Cardiol 2010;23:411–419)  相似文献   
77.
78.
Heart rate (HR), mean arterial pressure (MAP), indices of sympathetic and parasympathetic activity (plasma concentrations of adrenaline, noradrenaline and pancreatic polypeptide, PP), vasopressin (VP) and aldosterone (ALDO) were measured in six pigs during continuous bleeding resulting in hypovolaemic shock, from which five survived. Three stages of haemorrhage could be defined. Stage I. Resting MAP was 85 ± 6 mmHg and increased to 96 ± 5 mmHg with a blood loss of 275 (range 250–300) (10 (9–12)% of the estimated blood volume) concomitant with an increase in HR from 105 ± 5 to 113 ± 6 beats min-1 (P < 0.05). Stage II. After a blood loss of 375 (300–500) ml (15 (13–16)%) MAP fell to 62 ± 9 mmHg and HR to 95 ± 5 beats min-1 (P < 0.05). Stage III. A blood loss of 1113 (825–1450) ml (44 (30–52)%) resulted in a MAP of 50 ± 4 mmHg and an increase in HR to 206 ± 3 beats min-1 (P < 0.05). Adrenaline increased from 0.3 ± 0.1 to 0.8 ± 0.3 (stage II) and 3.6 ± 1.1 nmol l-1 (stage III) (P < 0.05); noradrenaline from 0.4 ± 0.1 to 1.5 ± 0.4 (stage II) and 5.9 ± 1.7 nmol l-1 (stage III) (P < 0.05); PP from 6.2 ± 1.6 to 13.3 ± 2.3 (stage II) and 20.9 ± 7.8 pmol l-1 (stage III) (P < 0.05). VP changed only marginally, but ALDO increased from 496 ± 54 to 623 ± 76 pmol l-1 (stage III) (P < 0.05). The results suggest that a high HR and intense sympathetic activity is seen during severe haemorrhage in the pig while vagal slowing of the heart and moderate hypotension are prominent when bleeding amounts to approximately 15% of the estimated blood volume.  相似文献   
79.
A study of the incorrect use of ventilator disconnection alarms   总被引:1,自引:0,他引:1  
  相似文献   
80.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号